The Melanoma Program at Smilow Cancer Hospital involves a multidisciplinary team developed over 25 years ago to discover new treatments and provide state-of-the-art treatment for our patients. In order to achieve these objectives, we bring together scientists, specialists in melanoma surgery, medical oncologists devoted to melanoma treatment, dermatologists, pathologists, dermatopathologists, radiologists, geneticists and psychotherapists.
The basic foundations of our Melanoma Program are basic research, clinical research, and skilled multidisciplinary care of patients. We have made fundamental contributions to the understanding of melanoma biology. The Yale SPORE in Skin Cancer grant from the National Institutes of Health, is one of only five such grants in the country; it supports multiple research projects in melanoma that translate basic science into clinical applications.